SUBSCRIBE
SUBSCRIBE
Pharm Country

Advaxis, Inc. to Present at the LD MICRO Growth Conference

November 17, 2009 | 
1 min read
NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) biotechnology company, has been invited to present at the LD MICRO Growth Conference on Thursday, December 3, 2009 at 1:00 PM PST.
Events
MORE ON THIS TOPIC
Cityscape of Madrid’s financial district at dusk, featuring modern skyscrapers illuminated against the fading evening sky. This area on the North of the city stands out as a symbol of contemporary architecture and economic dynamism in the Spanish capital, blending urban sophistication with a tranquil twilight ambiance.
cancer
Merck/Moderna, Summit/Akeso and ADCs to headline ESMO 2026
October 19, 2026
 · 
8 min read
 · 
Tristan Manalac
Editorial
Eli Lilly and the LA Dodgers: A tale of 2 dynasties
October 8, 2026
 · 
3 min read
 · 
Heather McKenzie
Start of negative growth trend. Worsening forecast. Cessation of rise inertia, not enough power energy. The risk of recession and sliding into a crisis
Obesity
Zealand dips as Boehringer Ingelheim-partnered weight loss drug fails to impress—again
October 1, 2026
 · 
2 min read
 · 
Heather McKenzie
Silhouette of a small propeller plane landing or taking off on the runway backlit under a yellow sun at sunset at Sabadell airport.
Obesity
Superior weight loss, blood sugar control propel Lilly’s amylin-GIP/GLP-1 combo into Phase 3
September 30, 2026
 · 
3 min read
 · 
Heather McKenzie